Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
DECEMBER 12, 2022 – ANNOUNCEMENT NO. 13
Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
Please see attachment.